Pptn trifluoroacetate
CAS: 1160271-30-6
Ref. 3D-KWB27130
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Pptn trifluoroacetate is a drug candidate that is currently undergoing clinical trials as a potential treatment for Alzheimer's disease. It belongs to the group of pyridone derivatives, which are chemically related to butyrophenones. Pptn trifluoroacetate has been found to be effective in reducing the symptoms of Alzheimer's disease by inhibiting 5-HT1A receptor activation, which leads to increased brain levels of serotonin and dopamine. Pptn trifluoroacetate has also been found to have calcium binding properties that lead to increased release of acetylcholine from cells in the brain. This drug candidate has shown no significant side effects in animal studies and has been found to be safe for human use.
Propiedades químicas
Consulta técnica sobre: 3D-KWB27130 Pptn trifluoroacetate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
